.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Moodys
McKesson
Merck
Boehringer Ingelheim
Chubb
Colorcon
Queensland Health
Express Scripts
Fuji

Generated: November 18, 2017

DrugPatentWatch Database Preview

Cromolyn sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for cromolyn sodium and what is the scope of cromolyn sodium patent protection?

Cromolyn sodium
is the generic ingredient in seven branded drugs marketed by Actavis Mid Atlantic, Bausch And Lomb, Akorn, Mylan Speciality Lp, Apotex Inc, Perrigo, Pharmascience Inc, Micro Labs Ltd India, Wockhardt, Genera Pharms, Allergan, Blacksmith Brands, Watson Labs, Teva Pharms, Roxane, Hh And P, Alcon, Pack Pharms Llc, King Pharms Llc, Ucb Inc, King Pharms, and Sanofi Aventis Us, and is included in twenty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for cromolyn sodium. Sixteen suppliers are listed for this compound.

Pharmacology for cromolyn sodium

Medical Subject Heading (MeSH) Categories for cromolyn sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane
CROMOLYN SODIUM
cromolyn sodium
SOLUTION;INHALATION075175-001Sep 30, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Pack Pharms Llc
CROMOLYN SODIUM
cromolyn sodium
CONCENTRATE;ORAL202583-001Oct 27, 2011AARXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
CROMOLYN SODIUM
cromolyn sodium
SOLUTION;INHALATION075271-001Jan 18, 2000ANRXNoYes► Subscribe► Subscribe► Subscribe
Ucb Inc
GASTROCROM
cromolyn sodium
CAPSULE;ORAL019188-001Dec 22, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
INTAL
cromolyn sodium
CAPSULE;INHALATION016990-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Bausch And Lomb
CROMOLYN SODIUM
cromolyn sodium
SPRAY, METERED;NASAL075702-001Jul 3, 2001OTCNoYes► Subscribe► Subscribe► Subscribe
Perrigo
CROMOLYN SODIUM
cromolyn sodium
SPRAY, METERED;NASAL075427-001Dec 12, 2001OTCNoNo► Subscribe► Subscribe► Subscribe
Akorn
CROMOLYN SODIUM
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC074706-001Apr 29, 1998ATRXNoYes► Subscribe► Subscribe► Subscribe
Bausch And Lomb
CROMOLYN SODIUM
cromolyn sodium
SOLUTION;INHALATION075585-001Dec 21, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
CROMOLYN SODIUM
cromolyn sodium
SOLUTION;INHALATION075333-001Apr 30, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cromolyn sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp
GASTROCROM
cromolyn sodium
CONCENTRATE;ORAL020479-001Feb 29, 1996► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
SOLUTION;INHALATION018596-001May 28, 1982► Subscribe► Subscribe
Allergan
OPTICROM
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 1984► Subscribe► Subscribe
Allergan
OPTICROM
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 1984► Subscribe► Subscribe
Sanofi Aventis Us
INTAL
cromolyn sodium
CAPSULE;INHALATION016990-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
AEROSOL, METERED;INHALATION018887-001Dec 5, 1985► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
SOLUTION;INHALATION018596-001May 28, 1982► Subscribe► Subscribe
Ucb Inc
GASTROCROM
cromolyn sodium
CAPSULE;ORAL019188-001Dec 22, 1989► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
SOLUTION;INHALATION018596-001May 28, 1982► Subscribe► Subscribe
Sanofi Aventis Us
INTAL
cromolyn sodium
CAPSULE;INHALATION016990-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Covington
Cerilliant
Cantor Fitzgerald
Baxter
Deloitte
McKinsey
Harvard Business School
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot